Rush University Medical Center

Rush Preparing for COVID-19 Resurgence

Rush leaders, experts continue to plan for what pandemic could look in coming weeks and months

Newswise — With Chicago and Illinois seeing a surge in cases of COVID-19 and the city and state implementing new restrictions to lessen the spread of the disease, Rush University System for Health is preparing for a resurgence of cases. Rush will continue to diligently prepare and plan its response to the surge to ensure the safety of everyone in Rush hospitals and clinics and within the Rush community.

At Rush University Medical Center and across the Rush system, there has been a small increase in the number of patients hospitalized with COVID-19 so far, but it has not translated to an increase in mortality rates. Many of the new cases are in young adults who are less likely to develop severe symptoms and are able to recover at home.

“While we are cautiously optimistic that we will not experience the same high numbers of hospitalized patients that we experienced in the spring we are prepared for that scenario,” said Dr. Paul Casey, chief medical officer at Rush University Medical Center. “Our concern is patients will defer routine care which can be detrimental to one’s health so we are planning to remain open for all procedures, surgeries and appointments in order to care for all of our patients’ needs.”

In the face of adversity, Rush set the standard for COVID-19 care and received national recognition for its preparedness. In spring 2020, Rush was able to successfully care for the sickest COVID-19 patients, receiving hundreds of transfers from other hospitals that couldn’t provide the care patients needed, while maintaining safe and excellent care for the vast majority of patients who sought treatment from Rush for other medical conditions.

Even when positivity rates of COVID-19 tests began to fall, Rush leaders continued to meet to discuss what the future could bring. Because of this dedication to planning for the unknown, Rush has been able to ramp up its COVID-19 testing — the System has tested more than 90,000 people to date — and maintain a healthy level of personal protective equipment for staff, patients and visitors alike.

As a participant in multiple clinical trials, Rush has learned a significant amount about the most effective treatment for COVID-19. The development of the Illinois Department of Public Health’s resurgence plan has provided better regional tracking of cases and mitigation steps. In addition, Rush has helped hospitals throughout both the city and the country to be more prepared to care for patients with COVID-19.

“We know Rush is the place where people will come when they run out of options. Be assured that Rush will forever stand with patients in need,” said Dr. Omar Lateef, CEO of Rush University Medical Center. “We provide care safely for the vast majority of our patients who have conditions other than COVID-19 while also treating patients with the disease. We plan to continue to do so — offering the procedures, surgeries and all of the excellent care that our patients need.”

“Fortunately, we are in a very different place now compared to our initial surge in cases more than six months ago,” added Angelique Richard, PhD, RN, CENP, chief nursing officer, Rush University System for Health and Rush University Medical Center, and senior vice president of hospital operations, Rush University Medical Center. “COVID-19 testing is much more widely available, which not only contributes to the increase in reported cases, but also means people diagnosed with COVID-19 can take necessary precautions to prevent further spread.”

While Casey, Richard and the rest of Rush’s leadership team are planning for a challenging winter, Casey says basic common-sense public health approaches can make a big difference in reducing the impact of this second surge. Frequent hand washing, adhering to universal masking guidelines and social distancing are all scientifically proven methods to prevent the spread of COVID-19.  Staying home this winter also can greatly reduce your risk and the risk of infecting others.

“COVID-19 is among the greatest challenges Rush and the world have faced. We will get through this, because everyone at Rush has been exceptional, collaborative and resilient,” Casey said.  “When this challenge is behind us, and it will be, we will look back on it with immense pride at what we have done to save lives, improve health and protect our community.”




Filters close

Showing results

110 of 4145
Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVID’s Collateral Damage: Germicidal Lamps May Damage Corneas
Released: 24-Nov-2020 5:15 PM EST
COVID’s Collateral Damage: Germicidal Lamps May Damage Corneas
University of Miami Health System, Miller School of Medicine

In a paper published in the journalOcular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus, developed painful inflammation of the cornea, a condition called photokeratitis.


Showing results

110 of 4145

close
1.24237